Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
107 studies found for:    hemophilia | Open Studies
Show Display Options
Rank Status Study
1 Recruiting TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia
Condition: Haemophilia A
Intervention: Other: Thrombin generation measurement.
2 Recruiting Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
Condition: Haemophilia
Intervention: Other: Patients with haemophilia
3 Recruiting The Hemophilia Ultrasound Project
Conditions: Hemophilia A;   Hemophilia B
Interventions: Other: Ankle and Knee Ultrasound Joint Assessment;   Other: Ankle and Knee Magnetic Resonance Imaging
4 Not yet recruiting Hemophilia Inhibitor Prevention (INHIBIT) Trial
Condition: Severe Hemophilia A
Intervention: Drug: Long-acting recombinant factor VIII Fc fusion protein
5 Recruiting Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia
Condition: Hemophilia
Intervention:
6 Recruiting Adherence to Treatment in Hemophilia
Condition: Haemophilia
Intervention:
7 Not yet recruiting Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?
Condition: Hemophilia
Interventions: Device: Chronometric method;   Device: Chromogenic method;   Device: Thrombin generation test (TGT)
8 Recruiting Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
Condition: Hemophilia A
Intervention: Drug: Available Recombinant, and Human Factor VIII products incl. Kogenate FS (Recombinant Factor VIII, BAY14-2222)
9 Recruiting Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.
Condition: Hemophilia A
Intervention: Other: Endurance training program
10 Recruiting Factor Product Utilization and Health Outcomes in Patients With Hemophilia
Conditions: Hemophilia A, Congenital;   Hemophilia B, Congenital
Intervention:
11 Recruiting Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
12 Recruiting A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN 2)
Condition: Hemophilia A
Intervention: Drug: Emicizumab
13 Recruiting Weight-based Dosing in Hemophilia A
Condition: Hemophilia
Intervention: Drug: rFVIII
14 Recruiting National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Behavioral: Educational Package
15 Recruiting Hemophilia Inhibitor Previously Untreated Patient Study
Condition: Hemophilia A
Intervention: Drug: FVIII concentrate
16 Not yet recruiting German Pediatric Hemophilia Research Database
Conditions: Hemophilia A;   Hemophilia B;   Children;   Drug Specific Antibodies
Intervention: Other: documentation only
17 Recruiting ATHN 2: Factor Switching Study
Condition: Hemophilia
Interventions: Biological: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013;   Biological: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
18 Not yet recruiting PF-06741086 Multiple Dose Study in Severe Hemophilia
Condition: Hemophilia A or B
Intervention: Biological: PF-06741086
19 Recruiting Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
Condition: Hemophilia A
Intervention: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
20 Recruiting Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: AAV5-hFIX

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.